RecruitingNCT07316751

Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease


Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

190 participants

Start Date

Oct 8, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to translate and validate the Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) into Italian to enable the assessment of gastrointestinal symptoms in Italian-speaking patients with Parkinson's disease. The psychometric properties of the translated instrument will be evaluated through a multi-phase process involving translation/back-translation, pre-testing, and large-scale validation across multiple Italian centers


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18 years;
  • Diagnosis of PD according to the Movement Disorder Society (MDS) diagnostic criteria (Postuma RB et al., 2015);
  • Italian-native patients or patients that understand Italian correctly at least;
  • Participants mentally and physically able to understand and sign the informed consent form.

Exclusion Criteria3

  • Persons in the terminal phase of disease;
  • Persons with clinically relevant cognitive impairment;
  • Persons diagnosed with Parkinsonism other than PD.

Locations(5)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Ospedale Universitario Luigi Sacco, Milano, Italia

Milan, Italy

Unità Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze(DNS), Università di Padova, Padova, Italia

Padua, Italy

Centro per le Malattie Neurodegenerative e l'Invecchiamento Cerebrale, Università degli Studi di Bari "Aldo Moro" presso la Pia Fondazione "Card. G. Panico", Tricase, Italia

Tricase, Italy

Unità di Neurologia, Divisione Malattia di Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, Italia

Verona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07316751


Related Trials